Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Change in Cash (2023 - 2025)

Historic Change in Cash for Immunocore Holdings (IMCR) over the last 3 years, with Q3 2025 value amounting to $2.7 million.

  • Immunocore Holdings' Change in Cash fell 8701.27% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$54.4 million, marking a year-over-year decrease of 17610.84%. This contributed to the annual value of $14.8 million for FY2024, which is 5350.74% down from last year.
  • Per Immunocore Holdings' latest filing, its Change in Cash stood at $2.7 million for Q3 2025, which was down 8701.27% from -$780000.0 recorded in Q2 2025.
  • Over the past 5 years, Immunocore Holdings' Change in Cash peaked at $391.0 million during Q1 2024, and registered a low of -$327.7 million during Q2 2024.
  • Moreover, its 3-year median value for Change in Cash was $10.2 million (2023), whereas its average is $5.6 million.
  • Data for Immunocore Holdings' Change in Cash shows a peak YoY increase of 275877.75% (in 2024) and a maximum YoY decrease of 330403.83% (in 2024) over the last 5 years.
  • Quarter analysis of 3 years shows Immunocore Holdings' Change in Cash stood at -$12.3 million in 2023, then crashed by 461.17% to -$69.0 million in 2024, then skyrocketed by 103.86% to $2.7 million in 2025.
  • Its Change in Cash was $2.7 million in Q3 2025, compared to -$780000.0 in Q2 2025 and $12.7 million in Q1 2025.